{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:36:11Z","timestamp":1780472171131,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xinjiang Key Laboratory of Neurological Disorder Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04121-8","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T08:09:21Z","timestamp":1742458161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Value of blood biomarkers in the diagnosis of Parkinson\u2019s disease: a case-control study from Xinjiang"],"prefix":"10.1186","volume":"25","author":[{"given":"Rurui","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abudula","family":"Aisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanati","family":"Nuerlanbieke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailiyaer","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"23","key":"4121_CR1","first-page":"4376","volume":"20","author":"M HUANG","year":"2022","unstructured":"Huang M, Yanna Y, Zhang H, et al. Clinical value of transcranial ultrasonography of nigrostriatal strong echoes in the diagnosis of Parkinson\u2019s disease [J]. Chin J Integr Med Cardio\/Cerebrovascular Disease. 2022;20(23):4376\u20139.","journal-title":"Chin J Integr Med Cardio\/Cerebrovascular Disease"},{"issue":"11","key":"4121_CR2","first-page":"1175","volume":"32","author":"C XU","year":"2016","unstructured":"Xu C, Ping Z, Li Y. Advances in clinical staging of Parkinson\u2019s disease [J]. Chin J Neurosurg. 2016;32(11):1175\u20138.","journal-title":"Chin J Neurosurg"},{"issue":"6","key":"4121_CR3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review[J]. JAMA. 2020;323(6):548\u201360.","journal-title":"JAMA"},{"key":"4121_CR4","doi-asserted-by":"crossref","unstructured":"Tolosa E, Garrido A, Scholz SW et al. Challenges in the diag\u2019nosis of Parkinson\u2019s disease[J]. Lancet Neurol. 2021;20(5):385\u201397.","DOI":"10.1016\/S1474-4422(21)00030-2"},{"key":"4121_CR5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.talanta.2016.03.035","volume":"153","author":"J DUAN","year":"2016","unstructured":"Duan J, Yu J, Feng S, et al. A rapid microwave synthesis of nitrogen-sulfur co-doped carbon nanodots as highly sensitive and selective fluorescence probes for ascorbic acid [J]. Talanta. 2016;153:332\u20139.","journal-title":"Talanta"},{"key":"4121_CR6","doi-asserted-by":"crossref","unstructured":"Aloia E, Sciaccaluga C. Low acid uric in primary prophylaxis: worthy? [J]. Int J Cardiol. 2016;215:223\u20136.","DOI":"10.1016\/j.ijcard.2016.04.065"},{"issue":"6","key":"4121_CR7","doi-asserted-by":"crossref","first-page":"e2854","DOI":"10.1038\/cddis.2017.240","volume":"8","author":"J ZOU","year":"2017","unstructured":"Zou J, Chen Z, Wei X, et al. Cystatin C as a potential therapeutic mediator against Parkinson\u2019s disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units [J]. Cell Death Dis. 2017;8(6):e2854.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4121_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E TOLOSA","year":"2006","unstructured":"Tolosa E, Wenning G. The diagnosis of Parkinson\u2019s disease [J]. Lancet Neurol. 2006;5(1):75\u201386.","journal-title":"Lancet Neurol"},{"issue":"7","key":"4121_CR9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.10473","volume":"18","author":"The Unified Parkinson\u2019s Disease Rating Scale (UPDRS)","year":"2003","unstructured":"The Unified Parkinson\u2019s Disease Rating Scale (UPDRS). Status and recommendations [J]. Mov Disord. 2003;18(7):738\u201350.","journal-title":"Mov Disord"},{"issue":"9","key":"4121_CR10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"G GOETZ C","year":"2004","unstructured":"Goetz CG, Poewe W. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations [J]. Mov Disord. 2004;19(9):1020\u20138.","journal-title":"Mov Disord"},{"issue":"9","key":"4121_CR11","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1007\/s12035-016-0193-8","volume":"54","author":"CA Martin-Jim\u00e9nez","year":"2017","unstructured":"Martin-Jim\u00e9nez CA, Gait\u00e1n-Vaca DM, Echeverria V, et al. Relationship between obesity, Alzheimer\u2019s disease, and Parkinson\u2019s disease: an astrocentric view[J]. Mol Neurobiol. 2017;54(9):7096\u2013115.","journal-title":"Mol Neurobiol"},{"key":"4121_CR12","doi-asserted-by":"crossref","unstructured":"Fan B, Jabeen R, Bo B, Guo C, Han M, Zhang H, Cen J, Ji X, Wei J. What and how can physical activity prevention function on Parkinson\u2019s disease? Oxid Med Cell Longev. 2020;2020:4293071.","DOI":"10.1155\/2020\/4293071"},{"issue":"1","key":"4121_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41531-022-00353-4","volume":"8","author":"KY Park","year":"2022","unstructured":"Park KY, Nam GE, Han K, Park HK, Hwang HS. Waist circumference and risk of Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8(1):89.","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"4121_CR14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s42255-023-00816-9","volume":"5","author":"KA van Galen","year":"2023","unstructured":"van Galen KA, Schrantee A, Ter Horst KW, et al. Brain responses to nutrients are severely impaired and not reversed by weight loss in humans with obesity: a randomized crossover study[J]. Nat Metab. 2023;5(6):1059\u201372.","journal-title":"Nat Metab"},{"key":"4121_CR15","doi-asserted-by":"crossref","unstructured":"Chen J, Guan Z, Wang L et al. Meta-analysis: overweight, obesity, and Parkinson\u2019s disease[J]. Int J Endocrinol. 2014;2014:203930.","DOI":"10.1155\/2014\/203930"},{"issue":"1","key":"4121_CR16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1468-1331.2012.03745.x","volume":"20","author":"S JES\u00faS","year":"2013","unstructured":"Jes\u00fas S, P\u00e9rez I, C\u00e1ceres-Redondo MT, et al. Low serum uric acid concentration in Parkinson\u2019s disease in Southern Spain [J]. Eur J Neurol. 2013;20(1):208\u201310.","journal-title":"Eur J Neurol"},{"issue":"8","key":"4121_CR17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jocn.2015.02.015","volume":"22","author":"P LOLEKHA","year":"2015","unstructured":"Lolekha P, Wongwan P. Association between serum uric acid and motor subtypes of Parkinson\u2019s disease [J]. J Clin Neurosci. 2015;22(8):1264\u20137.","journal-title":"J Clin Neurosci"},{"issue":"45","key":"4121_CR18","doi-asserted-by":"crossref","first-page":"e8502","DOI":"10.1097\/MD.0000000000008502","volume":"96","author":"Z YU","year":"2017","unstructured":"Yu Z, Zhang S, Wang D, et al. The significance of uric acid in the diagnosis and treatment of Parkinson disease: an updated systemic review [J]. Med (Baltim). 2017;96(45):e8502.","journal-title":"Med (Baltim)"},{"issue":"8","key":"4121_CR19","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/mds.25441","volume":"28","author":"R URIBE-SAN MART\u00edN","year":"2013","unstructured":"Uribe-San Mart\u00edn R, Venegas Francke P, L\u00f3pez Illanes F, et al. Plasma urate in REM sleep behavior disorder [J]. Mov Disord. 2013;28(8):1150\u20131.","journal-title":"Mov Disord"},{"issue":"4","key":"4121_CR20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11910-012-0282-7","volume":"12","author":"X CHEN","year":"2012","unstructured":"Chen X, WU G, Schwarzschild MA. Urate in Parkinson\u2019s disease: more than a biomarker? [J]. Curr Neurol Neurosci Rep. 2012;12(4):367\u201375.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4121_CR21","doi-asserted-by":"crossref","unstructured":"Borghi C et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33(9):1729\u201341; discussion 1741.","DOI":"10.1097\/HJH.0000000000000701"},{"key":"4121_CR22","doi-asserted-by":"crossref","unstructured":"Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension (Dallas, Tex.: 1979). 2003;42(3):247\u201352.","DOI":"10.1161\/01.HYP.0000085858.66548.59"},{"issue":"2","key":"4121_CR23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpneph0019","volume":"1","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa T, et al. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol Vol. 2005;1(2):80\u20136.","journal-title":"Nat Clin Pract Nephrol Vol"},{"key":"4121_CR24","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","volume":"164","author":"LK Niskanen","year":"2004","unstructured":"Niskanen LK, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Archives Intern Med Vol. 2004;164:1546\u201351.","journal-title":"Archives Intern Med Vol"},{"issue":"12","key":"4121_CR25","first-page":"2004","volume":"14","author":"M YE","year":"2016","unstructured":"Ye M, Chen Y, Liu X, et al. The clinical significance of serum Cystatin C level change in Parkinson\u2019s disease [J]. Chin J Gen Pract. 2016;14(12):2004\u20137.","journal-title":"Chin J Gen Pract"},{"issue":"8","key":"4121_CR26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4103\/0366-6999.229902","volume":"131","author":"J XIONG K P, DAI Y P, CHEN","year":"2018","unstructured":"Xiong KP, Dai YP, Chen J, et al. Increased serum Cystatin C in early Parkinson\u2019s disease with objective sleep disturbances [J]. Chin Med J (Engl). 2018;131(8):907\u201311.","journal-title":"Chin Med J (Engl)"},{"key":"4121_CR27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.arr.2016.06.003","volume":"32","author":"PM MATHEWS","year":"2016","unstructured":"Mathews PM. Cystatin C in aging and in Alzheimer\u2019s disease [J]. Ageing Res Rev. 2016;32:38\u201350.","journal-title":"Ageing Res Rev"},{"issue":"10","key":"4121_CR28","doi-asserted-by":"crossref","first-page":"e1497","DOI":"10.1038\/cddis.2014.459","volume":"5","author":"S WATANABE","year":"2014","unstructured":"Watanabe S, Hayakawa T, Wakasugi K, et al. Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity [J]. Cell Death Dis. 2014;5(10):e1497.","journal-title":"Cell Death Dis"},{"issue":"2","key":"4121_CR29","first-page":"113","volume":"25","author":"FENG T","year":"2023","unstructured":"Feng T. Applying biological markers to improve the diagnosis of Parkinson\u2019s disease [J]. Chin J Geriatric Heart Brain Vessel Dis. 2023;25(2):113\u20136.","journal-title":"Chin J Geriatric Heart Brain Vessel Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04121-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04121-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04121-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T08:10:54Z","timestamp":1742458254000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04121-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4121"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04121-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Second Affiliated Hospital of Xinjiang Medical University, all methods were carried out in accordance with relevant guidelines and regulations. The Ethics Committee of the Second Affiliated Hospital of Xinjiang Medical University waived the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}